Pacira BioSciences (PCRX) Amortization of Goodwill (2024)

Pacira BioSciences (PCRX) recorded quarterly Amortization of Goodwill of $163.2 million in Q3 2024.

Pacira BioSciences (PCRX) Amortization of Goodwill (2024) Analysis & Trends

Pacira BioSciences' Amortization of Goodwill history runs 1 years deep, the most recent figure standing at $163.2 million for Q3 2024.

  • In Q3 2024, Amortization of Goodwill changed N/A year-over-year to $163.2 million; the TTM figure through Dec 2025 stood at $163.2 million (changed N/A YoY), while the FY2024 annual figure was $163.2 million, changed N/A from the prior year.
  • Amortization of Goodwill was $163.2 million for Q3 2024 at Pacira BioSciences.
  • In the past five years, Amortization of Goodwill ranged from a high of $163.2 million in Q3 2024 to a low of $163.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Pacira BioSciences 940.31 Mn 738.13 Mn 140.96 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 163.20 Mn
Sep 30, 2024 163.20 Mn